Sentinel lymphatic mapping for gynecologic malignancies.
Publication Title
Current opinion in obstetrics & gynecology
Document Type
Article
Publication Date
2-1-2023
Keywords
california; psjh; Humans; Female; Genital Neoplasms, Female; Sentinel Lymph Node Biopsy; Lymphatic Metastasis; Lymph Node Excision; Vulvar Neoplasms; Uterine Cervical Neoplasms; Endometrial Neoplasms; Lymph Nodes; Neoplasm Staging
Abstract
PURPOSE OF REVIEW: To summarize the latest data in Gynecologic Oncology for the use of sentinel lymphatic mapping in vulvar, uterine, and cervical cancers.
RECENT FINDINGS: To decrease morbidity and improve detection of lymphatic metastasis, lymphatic mapping with sentinel lymph node biopsy is emerging as standard of care over conventional systemic lymphadenectomy in the surgical management of gynecologic malignancies.
SUMMARY: Sentinel lymph node mapping with biopsy is one of the most significant advances in cancer surgery. The presence of nodal metastasis is not only a prognostic factor for recurrence and survival in patients with gynecologic malignancies, but also guides assessment for adjuvant treatment. This review article discusses the most recent clinical updates in sentinel lymph node mapping, dissection, and management in vulvar cancer, endometrial cancer, and cervical cancer.
Clinical Institute
Cancer
Clinical Institute
Women & Children
Specialty/Research Institute
Obstetrics & Gynecology
Specialty/Research Institute
Oncology
DOI
10.1097/GCO.0000000000000841
